XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues:    
Total revenues $ 964,322  
Operating expenses:    
Research and development 7,026,066 $ 5,643,029
General and administrative 3,733,001 3,137,958
Total operating expenses 10,759,067 8,780,987
Loss from operations (9,794,745) (8,780,987)
Other income (expenses):    
Arbitration settlement (118,880)  
Interest income 3,117 1,537
Net loss $ (9,910,508) $ (8,779,450)
Net loss per share, basic $ (0.12) $ (0.16)
Net loss per share, diluted $ (0.12) $ (0.16)
Weighted average number of common shares outstanding, basic 83,107,649 56,470,247
Weighted average number of common shares outstanding, diluted 83,107,649 56,470,247
Grant income    
Revenues:    
Total revenues $ 964,322